China to reimburse more cancer and diabetes drugs
This article was originally published in Scrip
Executive Summary
The effect of China's national healthcare reform plan may still be debated, but it now looks as if there will be one positive change for patients with cancer and diabetes.
You may also be interested in...
Impressive healthcare sector growth in China last year
Total sales in China's healthcare industry reached Yuan825.38 billion ($127.45 billion) in 2008, a surge of 26% from the previous year, according to new data from the State FDA.
China unveils new healthcare reform plan
An initial draft of China's much-anticipated healthcare reform plan was released by the ministry of health (MoH) and National Development and Reform Commission in the middle of October, and has been opened up to the public for debate and feedback.